Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Moncef Slaoui, the former head of GlaxoSmithKline vaccines division, listens as U.S. President Donald Trump delivers remarks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020 in Washington, D.C. (Photo: Drew Angerer/Getty Images)

'This Is My Retirement': Trump's Covid-19 Vaccine Czar Refuses to Sell Stock Holdings of Major Drug Company

"If he retains stock in companies that are investing in the development of a vaccine," said government watchdog CREW, "we can't be confident of the integrity of any process in which he is involved."

The chief adviser overseeing President Donald Trump's task force charged with spearheading the U.S. government's Covid-19 vaccine and treatment effort has refused to divest his shares in pharmaceutical company GlaxoSmithKline, where he previously worked.

As the New York Times reported Wednesday, Dr. Moncef Slaoui, who was appointed to lead Operation Warp Speed last week, holds nearly $10 million in stock at the company where he led the vaccine division until his retirement in 2017. Slaoui still owns an unknown number of shares at GSK, where he held about 240,000 shares and share equivalents when he left the company.

GSK is one of several pharmaceutical companies researching potential vaccines for the coronavirus.

Slaoui reportedly told the Trump administration that he would not sell his GSK shares.

"I have worked for 29 years for GSK," Slaoui told the Times. "I have never sold a single share of any company in my life. This is my retirement. What I said regarding the GSK shares, I said I cannot take the job if I have to sell them."

Critics charge Slaoui's interest in GSK represents just one of his conflicts as he leads a task force which will decide which vaccine candidates should receive financial backing. 

The doctor has retained his partnership in the venture capital firm Medicxi, which has investments in a number of companies researching vaccines and treatments. 

Under Slaoui's arrangement with the Trump administration, he is working on Operation Warp Speed as a contractor rather than a federal employee, shielding him from conflict of interest laws and financial disclosure rules—a deal the government watchdog Citizens of Responsibility and Ethics in Washington (CREW) called "absurd."

"It allows for no public scrutiny of his conflicts of interest," chief ethics counsel Virginia Canter told the Times. "If he retains stock in companies that are investing in the development of a vaccine, and he's involved in overseeing this process to select the safest vaccine to combat Covid-19, regardless of how wonderful a person he is, we can't be confident of the integrity of any process in which he is involved."

Last week, Sen. Elizabeth Warren (D-Mass.) called on Slaoui to "immediately divest" his financial interests in Moderna, another pharmaceutical company researching a vaccine. When Slaoui accepted his new position, he still held stock options in the company, amounting to what Warren called "a huge conflict of interest."

Slaoui did not sell those shares until this Tuesday, a day after Moderna's stock skyrocketed when the company released partial data from an early vaccine trial, which showed eight out of 45 test subjects had developed Covid-19 immunity.

Slaoui's stock options increased by more than $2 million after the announcement; the Trump administration said he was planning to donate the increased value to cancer research. 

Despite Moderna's rising stock during its vaccine trial demonstrating how Slaoui's involvement in the task force creates conflicts for the doctor, the White House told the Times it had "reviewed Dr. Slaoui's affiliations with several companies and concluded in several instances that there were no conflicts because his advisory roles were unrelated to coronavirus research or treatments."

On Thursday, former Office of Government Ethics director Walter Shaub tweeted that the arrangement allowing Slaoui to work as a contractor while overseeing government employees working on Operation Warp Speed is a "sham."

Slaoui's position on the task force "would make him a special government employee subject to the criminal conflict of interest law," wrote Shaub. "Congress needs to investigate!" 


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
We need your help.

Support progressive journalism.

Common Dreams is not your average news site. We don't survive on clicks or advertising dollars. We rely entirely on your support. And without it, our independent progressive journalism simply wouldn’t exist. Every gift of every amount matters.

Join the fight and support our common dreams today.

'A Deeply Dangerous Order': Trump-Appointed Judge Blocks Biden From Pausing New Oil Drilling Leases

"The judge's order turns a blind eye to runaway climate pollution that's devastating our planet."

Jake Johnson, staff writer ·


After Far-Right Marchers Chant 'Death to Arabs,' New Israeli Government Bombs Gaza

"The problem is bigger than Netanyahu—it's apartheid."

Jake Johnson, staff writer ·


Progressives, Big Tech Critics Celebrate Confirmation of Lina Khan as FTC Chair

"Her presence on the FTC marks the beginning of the end of an era of lawlessness for powerful corporations that they've enjoyed at the expense of workers, smaller businesses, and democracy."

Jessica Corbett, staff writer ·


'Our Democracy Hangs in the Balance': Calls Grow for Justice Breyer to Retire

"Democrats could lose our razor-thin majority in the Senate at any moment," warns Rep. Mondaire Jones. "It would be irresponsible to leave the future of our democracy up to chance."

Brett Wilkins, staff writer ·


Share of Fossil Fuels in Global Energy Mix 'Has Not Moved by an Inch' in a Decade

"We are waking up to the bitter reality that the climate policy promises over the past 10 years have mostly been empty words," said the executive director of REN21, which released the new report.

Jessica Corbett, staff writer ·